{
  "id": 14995893,
  "title": "Keytruda Biosimilar Advances; Oncologist Turned Patient; Will AI Cure Cancer?",
  "url": "https://urgent.news/2026/10/16/keytruda-biosimilar-advances-oncologist-turned-patient-will-ai-cure",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-16T15:40:59.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/hematologyoncology/othercancers/123448"
  },
  "original_language": "en",
  "account": "Zydus Lifesciences and Formycon AG received approval from the FDA for FYB206, a biosimilar of the widely-used cancer medication Keytruda. The U.S. Food and Drug Administration also broadened the use of nogapendekin alfa, a drug called Anktiva, to include a specific type of non-muscle invasive bladder cancer that does not respond to bacillus Calmette-Guérin. Tragically, Rachna Shroff, MD, a respected professional in gastrointestinal cancer research, passed away at the age of 47 due to an undisclosed form of cancer.\n\nExperts advise caution when using BI-RADS, a breast cancer reporting system typically designed for adults, when assessing breast masses in children, as these instances are rare and typically benign. An oncologist who has been treating breast cancer patients for 25 years shared insights gained through personal experience with the disease. While young women often face delays in breast cancer diagnosis and treatment, a study in Cancer magazine highlights this disparity. Racing driver Jack Harvey, 33, disclosed a cancer diagnosis on social media, though he did not specify the type. Undeterred, he remains optimistic about competing in the Indianapolis 500 in May 2027.\n\nA recent ecological study published by the University of Hawaii indicates that coastal counties with elevated levels of marine microplastics are linked to higher incidences of various cancers. Bristol Myers Squibb announced that the investigational drug 225Ac-Dotatate significantly enhanced progression-free survival in patients with previously treated gastroenteropancreatic neuroendocrine tumors that could not be managed by standard treatments. Adding the PSMA-targeted radiopharmaceutical 177Lu-PNT2002 to stereotactic body radiotherapy for recurrent prostate cancer further lowered the risk of progression, according to an updated analysis of the phase II LUNAR trial. Merck's CEO expressed confidence in the efficiency of the production process for their personalized cancer vaccine, developed in collaboration with Moderna. BioNTech's findings reveal that combining their mRNA cancer vaccine BNT113 with pembrolizumab did not result in improved progression-free survival for metastatic HPV-positive head and neck cancer.\n\nPope Leo's diagnosis with lung cancer and subsequent surgery garnered widespread attention, while his brother Louis Prevost began treatment for multiple myeloma. The American Society of Hematology released new clinical guidance on myelofibrosis, emphasizing the importance of molecular testing, early referral for stem cell transplantation, and the judicious use of JAK inhibitors and aspirin. Amidst these developments, some AI researchers, convinced that artificial intelligence will conquer cancer, are even embracing smoking as a coping mechanism, according to Palantir's chief technical officer. Another promising development comes from Ohio State University, where an enhanced CAR T-cell therapy demonstrated potential in improving outcomes for relapsed or refractory B-cell malignancies. Lastly, Abbott Laboratories announced that they have enlisted the support of retired MLB star Albert Pujols and current player Cal Raleigh to promote their Cologuard Plus colon cancer test.",
  "summary": "(MedPage Today) -- Zydus Lifesciences and Formycon AG announced FDA acceptance of a biologics license application for FYB206, a biosimilar to the blockbuster cancer drug pembrolizumab (Keytruda). The FDA expanded bladder cancer indications for...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}